SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(McLaren S)
 

Sökning: WFRF:(McLaren S) > (2015-2019) > Patterns and predic...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00008329naa a2201153 4500
001oai:gup.ub.gu.se/266334
003SwePub
008240528s2018 | |||||||||||000 ||eng|
009oai:lup.lub.lu.se:b5af0956-5f33-464b-a969-bead190d3d1b
024a https://gup.ub.gu.se/publication/2663342 URI
024a https://doi.org/10.1136/annrheumdis-2017-2119122 DOI
024a https://lup.lub.lu.se/record/b5af0956-5f33-464b-a969-bead190d3d1b2 URI
040 a (SwePub)gud (SwePub)lu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Herrick, A. L.u University of Manchester,Christie NHS Foundation Trust4 aut
2451 0a Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
264 c 2018-01-06
264 1b BMJ,c 2018
520 a Objectives Our aim was to use the opportunity provided by the European Scleroderma Observational Study to (1) identify and describe those patients with early diffuse cutaneous systemic sclerosis (dcSSc) with progressive skin thickness, and (2) derive prediction models for progression over 12 months, to inform future randomised controlled trials (RCTs). Methods The modified Rodnan skin score (mRSS) was recorded every 3 months in 326 patients. 'Progressors' were defined as those experiencing a 5-unit and 25% increase in mRSS score over 12 months (±3 months). Logistic models were fitted to predict progression and, using receiver operating characteristic (ROC) curves, were compared on the basis of the area under curve (AUC), accuracy and positive predictive value (PPV). Results 66 patients (22.5%) progressed, 227 (77.5%) did not (33 could not have their status assessed due to insufficient data). Progressors had shorter disease duration (median 8.1 vs 12.6 months, P=0.001) and lower mRSS (median 19 vs 21 units, P=0.030) than non-progressors. Skin score was highest, and peaked earliest, in the anti-RNA polymerase III (Pol3+) subgroup (n=50). A first predictive model (including mRSS, duration of skin thickening and their interaction) had an accuracy of 60.9%, AUC of 0.666 and PPV of 33.8%. By adding a variable for Pol3 positivity, the model reached an accuracy of 71%, AUC of 0.711 and PPV of 41%. Conclusions Two prediction models for progressive skin thickening were derived, for use both in clinical practice and for cohort enrichment in RCTs. These models will inform recruitment into the many clinical trials of dcSSc projected for the coming years. Trial registration number NCT02339441. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng
653 a autoantibodies
653 a outcomes research
653 a systemic sclerosis
700a Peytrignet, S.u University of Manchester4 aut
700a Lunt, M.u University of Manchester4 aut
700a Pan, X.u University of Manchester4 aut
700a Hesselstrand, Rogeru Lund University,Lunds universitet,Forskargruppen för systemisk skleros, Lund,Forskargrupper vid Lunds universitet,Lund Systemic Sclerosis Research Group,Lund University Research Groups4 aut0 (Swepub:lu)reum-rhe
700a Mouthon, L.u Paris Descartes University,University Medical Center Utrecht4 aut
700a Silman, A. J.u University of Oxford4 aut
700a Dinsdale, G.u University of Manchester4 aut
700a Brown, E.u University of Manchester4 aut
700a Czirják, L.u University of Pécs4 aut
700a Distler, J. H. W.u Friedrich-Alexander University Erlangen-Nürnberg,Gateshead Hospitals Foundation Trust4 aut
700a Distler, O.u University of Zurich4 aut
700a Fligelstone, K.u Royal Free London NHS Foundation Trust4 aut
700a Gregory, W. J.u Salford Royal NHS Foundation Trust4 aut
700a Ochiel, R.u Royal Free London NHS Foundation Trust4 aut
700a Vonk, M. C.u Radboud University Nijmegen4 aut
700a Ancu, C.u Grigore T. Popa University of Medicine and Pharmacy4 aut
700a Ong, V. H.u University College London4 aut
700a Farge, D.u Paris Diderot University,Saint-Louis Hospital, Paris4 aut
700a Hudson, M.u Jewish General Hospital,McGill University,University of Leeds,Leeds Teaching Hospitals NHS Trust4 aut
700a Matucci-Cerinic, M.u University of Florence4 aut
700a Balbir-Gurman, A.u Technion - Israel Institute of Technology4 aut
700a Midtvedt, O.4 aut
700a Jobanputra, P.u New Queen Elizabeth Hospital4 aut
700a Jordan, A. C.u New Queen Elizabeth Hospital,Nantes University Hospital,University of Nantes4 aut
700a Stevens, W.u St. Vincent's Hospital, Melbourne4 aut
700a Moinzadeh, P.u University of Cologne,University of Adelaide,Royal Adelaide Hospital4 aut
700a Hall, F. C.u University of Cambridge4 aut
700a Agard, C.4 aut
700a Anderson, M. E.u Aintree University Hospital,University of Liverpool4 aut
700a Diot, E.u Hopital Bretonneau4 aut
700a Madhok, R.u Glasgow Royal Infirmary4 aut
700a Akil, M.u Sheffield Teaching Hospitals4 aut
700a Buch, M. H.4 aut
700a Chung, L.u Stanford University4 aut
700a Damjanov, N. S.u University of Belgrade4 aut
700a Gunawardena, H.u North Bristol NHS Trust4 aut
700a Lanyon, P.u Nottingham University Hospitals NHS Trust4 aut
700a Ahmad, Y.u Peter Maddison Rheumatology Centre4 aut
700a Chakravarty, K.u Queen’s Hospital4 aut
700a Jacobsen, S.u Copenhagen University Hospital,University of Copenhagen4 aut
700a MacGregor, A. J.u University of East Anglia4 aut
700a McHugh, N.u Royal National Hospital for Rheumatic Diseases4 aut
700a Müller-Ladner, U.u Justus Liebig University Giessen4 aut
700a Riemekasten, G.u University of Lübeck4 aut
700a Becker, M.u Charité - University Medicine Berlin4 aut
700a Roddy, J.u Royal Perth Hospital4 aut
700a Carreira, P. E.u 12 de Octubre University Hospital4 aut
700a Fauchais, A. L.u University Hospital Of Limoges4 aut
700a Hachulla, E.u University of Lille4 aut
700a Hamilton, J.4 aut
700a Inanç, M.u Istanbul University4 aut
700a McLaren, J. S.u Whyteman's Brae Hospital,Monash University4 aut
700a Van Laar, J. M.4 aut
700a Pathare, S.u James Cook University Hospital4 aut
700a Proudman, S. M.4 aut
700a Rudin, Anna,d 1961u University of Gothenburg,Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för reumatologi och inflammationsforskning,Institute of Medicine, Department of Rheumatology and Inflammation Research4 aut0 (Swepub:gu)xrudan
700a Sahhar, J.4 aut
700a Coppere, B.u Hôpital Edouard Herriot4 aut
700a Serratrice, C.u Hospital Saint Joseph4 aut
700a Sheeran, T.u Cannock Chase Hospital4 aut
700a Veale, D. J.u St Vincent's University Hospital4 aut
700a Grange, C.u Centre Hospitalier Lyon Sud4 aut
700a Trad, G. S.u CHU Ambroise Paré4 aut
700a Denton, C. P.u University College London4 aut
700a Midtvedt, Øyvindu Oslo university hospital4 aut
710a University of Manchesterb Christie NHS Foundation Trust4 org
773t Annals of the Rheumatic Diseasesd : BMJg 77:4, s. 563-570q 77:4<563-570x 0003-4967x 1468-2060
856u https://ard.bmj.com/content/annrheumdis/77/4/563.full.pdf
856u http://dx.doi.org/10.1136/annrheumdis-2017-211912x freey FULLTEXT
8564 8u https://gup.ub.gu.se/publication/266334
8564 8u https://doi.org/10.1136/annrheumdis-2017-211912
8564 8u https://lup.lub.lu.se/record/b5af0956-5f33-464b-a969-bead190d3d1b

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy